SR ONE CAPITAL MANAGEMENT, LLC sold ODTX
May 11, 2026 · Form 4 insider transaction
SR ONE CAPITAL MANAGEMENT, LLC sold 764,312 shares of Odyssey Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as exercise of in-the-money option and disclosed on an SEC Form 4, filed 0 days after the transaction.
Footnotes
The warrants to purchase shares of common stock were automatically exercised into shares of Common Stock by their terms immediately prior to the closing of the Issuer's initial public offering on a net exercise basis.; The reported securities are held directly by AMZL, LP ("AMZL"). SR One Capital SMA Partners, LP ("SR One SMA Partners") is the general partner of AMZL, and SR One Capital Management is the general partner of SR One SMA Partners. Simeon George, M.D. is the managing member of SR One Capital Management. Each of SR One SMA Partners, SR One Capital Management and Dr. George may be deemed to have shared power to vote or dispose of these shares, and each disclaims beneficial ownership of the shares except to the extent of any pecuniary interest therein.